摘要
特应性皮炎(AD)是一种常见的慢性、复发性、炎症性疾病,其机制复杂、反复发作、异质性强、伴随终生,7年复发率高达75.9%,给患者及其家庭带来巨大且持久的经济和精神负担。除此之外,作为一种系统性疾病,AD常合并多种特异性及非特异性并发症,尤其是过敏性疾病。皮肤炎症是过敏进程的初始阶段,早期控制皮肤炎症对于后期阻断过敏进程具有重要意义。针对以上AD的特征,长期规律的治疗与管理尤为重要,这对于医务人员的诊疗水平、诊疗机构的流程建设、患者的自我管理能力及依从性有较高的要求。本文围绕AD的慢病管理模式内容展开了讨论,详细介绍了我国AD慢病管理现状,并从评估工具、达标治疗、共病管理、随访宣教等多个方面对AD慢病管理模式的建立进行了阐述。
Atopic dermatitis(AD)is a common chronic,recurrent,and inflammatory disease.Its mechanism is complex,recurrent,heterogeneous,and lifelong.The 7-year recurrence rate is as high as 75.9%,which brings a huge and lasting economic and mental burden to patients and their families.In addition,as a systemic disease,AD is often complicated with a variety of specific and non-specific complications,especially allergic diseases.Skin inflammation is the initial stage of the allergic process,and early control of skin inflammation is great significance for blocking the allergic process in the later stage.In view of the above characteristics of AD,long-term regular treatment and management are particularly important,which has high requirements for the diagnosis and treatment level of medical personnel,the process construction of diagnosis and treatment institutions,and the self-management ability and compliance of patients.This paper discusses the content of the chronic disease management model of AD,introduces the current situation of AD chronic disease management in China in detail,and elaborates the establishment of the chronic disease management model of AD from the aspects of assessment tools,treat-to-target,comorbidity management,and follow-up education.
作者
王晨昱
申晨
张亚敏
陶娟
WANG Chenyu;SHEN Chen;ZHANG Yamin;TAO Juan(Department of Dermatology,Union Hospital of Tongji Medical College,Huazhong University of Science Technology,Wuhan 430022,China)
出处
《皮肤科学通报》
2024年第1期51-56,共6页
Dermatology Bulletin
关键词
特应性皮炎
慢病管理
随访教育
达标治疗
Atopic dermatitis
Chronic disease management
Follow-up education
Treat-to-target
